glp-1 prescription requirements Long-term Success of GLP-1s Hinges on More Than Just a A new Medicare program is

For US HCPs.

Bridging the gap between clinical potential and real-world impact enables stakeholders to decode the complex interplay of these forces and rethink what it truly takes to keep patients on the path to sustained outcomes

Three scientists are honored for developing a class of blockbuster weight-loss drugs

Dulaglutide is a once-weekly injectable glucagon-like peptide-1 (GLP-1) receptor agonist that has shown a durable glycemic efficacy as well as beneficial effects on body weight andmajor adverse cardiovascular events (MACE) outcomes, making it an important option for the treatment of type 2 diabetes

Made in USA, plant-based

You can watch both free with a 7-day trial